stella
beta
Find trials matched to me
Trial Match
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma — Stella
Recruiting
Back to Hepatocellular Carcinoma Non-resectable trials
Trial locations
(2 sites)
China
The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian
TongjiHospital, Wuhan, Hubei
View full record on ClinicalTrials.gov